1. Chen, Xiaoying, Du, Yanhua, Broussard, Gerard Joey, Zhang, Xiaoqing, Bonni, Azad. 2022. Transcriptomic mapping uncovers Purkinje neuron plasticity driving learning. In Nature, 605, 722-727. doi:10.1038/s41586-022-04711-3. https://pubmed.ncbi.nlm.nih.gov/35545673/
2. El Fizazi, Khawla, Bouramtane, Abdelhamid, Abbassi, Meriame, Ridal, Mohammed, Bouguenouch, Laila. 2023. A homozygous missense variant in the PLCB4 gene causes severe phenotype of auriculocondylar syndrome type 2. In American journal of medical genetics. Part A, 191, 2673-2678. doi:10.1002/ajmg.a.63375. https://pubmed.ncbi.nlm.nih.gov/37596802/
3. Lin, Yunting, Zhang, Ye, Ma, Jian, Zeng, Chunhua, Luo, Xianqiong. 2024. Two Chinese Patients of Auriculocondylar Syndrome 2: A Novel PLCB4 Splicing Variant and 5-Year Follow-up. In The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association, , 10556656241234575. doi:10.1177/10556656241234575. https://pubmed.ncbi.nlm.nih.gov/38414442/
4. Johansson, Peter, Aoude, Lauren G, Wadt, Karin, Jönsson, Göran, Hayward, Nicholas K. . Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4. In Oncotarget, 7, 4624-31. doi:10.18632/oncotarget.6614. https://pubmed.ncbi.nlm.nih.gov/26683228/
5. Wu, Shiwen, Zhang, Wei, Shen, Dongqin, Lu, Jianle, Zhao, Li. 2019. PLCB4 upregulation is associated with unfavorable prognosis in pediatric acute myeloid leukemia. In Oncology letters, 18, 6057-6065. doi:10.3892/ol.2019.10921. https://pubmed.ncbi.nlm.nih.gov/31788080/
6. Zhang, Yongli, Zhao, Yuwei, Dai, Liying, Liu, Yu, Shi, Zifeng. . Auriculocondylar syndrome 2 caused by a novel PLCB4 variant in a male Chinese neonate: A case report and review of the literature. In Molecular genetics & genomic medicine, 12, e2441. doi:10.1002/mgg3.2441. https://pubmed.ncbi.nlm.nih.gov/38618928/
7. Li, Chien-Feng, Liu, Ting-Ting, Chuang, I-Chieh, Li, Wan-Shan, Huang, Hsuan-Ying. . PLCB4 copy gain and PLCß4 overexpression in primary gastrointestinal stromal tumors: Integrative characterization of a lipid-catabolizing enzyme associated with worse disease-free survival. In Oncotarget, 8, 19997-20010. doi:10.18632/oncotarget.15306. https://pubmed.ncbi.nlm.nih.gov/28212550/
8. Park, John J, Diefenbach, Russell J, Joshua, Anthony M, Carlino, Matteo S, Rizos, Helen. 2018. Oncogenic signaling in uveal melanoma. In Pigment cell & melanoma research, 31, 661-672. doi:10.1111/pcmr.12708. https://pubmed.ncbi.nlm.nih.gov/29738114/
9. Tsai, Dung-Jang, Fang, Wen-Hui, Wu, Li-Wei, Wu, Chia-Chun, Su, Sui-Lung. 2021. The Polymorphism at PLCB4 Promoter (rs6086746) Changes the Binding Affinity of RUNX2 and Affects Osteoporosis Susceptibility: An Analysis of Bioinformatics-Based Case-Control Study and Functional Validation. In Frontiers in endocrinology, 12, 730686. doi:10.3389/fendo.2021.730686. https://pubmed.ncbi.nlm.nih.gov/34899595/
智鼠故事 
